Company Research Highlights ®

Report created on January 11, 2010

CHEMTURA CORP (Other OTC:CEMJQ)

199 Benson Rd
Waterbury, CT 06749-0001
USA
203-573-2000
www.chemtura.com

Important Information Regarding Third-Party Content

This is not an investment recommendation from Fidelity Investments. Fidelity provides this
information as a service to investors from independent, third-party sources.
Performance of analyst recommendations are provided by StarMine.
Current analyst recommendations are collected and standardized by Investars.
See each section in this report for third-party content attribution, as well as the final page
of the report for additional important information regarding third-party content.
 Company Research Highlights ®This Other OTC CEMJQ
is not an investment recommendation from Fidelity Investments. Fidelity provides
this information as a service to investors from independent, third-party sources.

Price on 1/8/2010: $1.22 CHEMTURA CORP

Market Capitalization: $296.4

Company Vitals Data provided by S&P and 3-Year Price Performance Data provided by Reuters DataScope
Compustat

52 Week High $1.48

52 Week Low $0.016 0%
Beta 4.4
10 Day Average Volume 1.1 Million
Shares Outstanding 242.9 Million 200-Day Moving Average -50%
Institutional Ownership 24.0%
EPS: Most Recent Qtr. $0.05
EPS Growth: Most Recent Qtr. 0.0% 50-Day Moving Average -100%
EPS Growth: Past 5 Years 30.7% Average Monthly Volume (Millions)
Dividend Yield: Annual N/A 200

Dividend: Most Recent Qtr. $0.00 0

Employee Count 4,700 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4
2007 2008 2009
Business Summary Data provided by S&P
Compustat
Analyst Recommendations StarMine Ranking provided by StarMine; Recommendation data provided by Investars
Chemtura Corporation, together with its
subsidiaries, engages in the manufacture Most Accurate Analyst Recommendations
and sale of specialty chemical solutions and StarMine
consumer products in the United States. Its Standard Accuracy Last Change to Firm's Recommendation
products are used as additives, ingredients, Rec.¹ Firm Name² Score Date Action³ Recommendation
and intermediates.
No analysts currently have a StarMine Accuracy Score of 68 or higher for this stock.
Environmental, Social &
Governance Summary (ESG)
History of Most Accurate Analyst Recommendations
KLD Research ESG Composite Rating Number of Most Accurate Analysts
N/A Standard Recommendation Current Last Month 2 Months Ago 3 Months Ago
The ESG Composite rating enables you to Buy
leverage industry leading KLD ESG research Outperform
to learn if the company is adequately
(Yellow Rating) managing ESG risks and Neutral
addressing ESG opportunities; or more
effectively (Green Rating); or not effectively Underperform
(Red Rating). Sell
KLD Research Vice Alert To learn how most accurate analysts are calculated and information on all available analysts for CEMJQ, please click here, or log on to www.fidelity.com

Involved Not Involved

Other Analyst Recommendations
The Vice Alert indicates a company’s
StarMine
involvement in deriving at least 15% of
Standard Accuracy Last Change to Firm's Recommendation
revenue from adult entertainment, alcohol,
Rec.¹ Firm Name² Score Date Action³ Recommendation
gambling, and/or tobacco.
Standard & Poor's (i) 45 10/16/08 Downgrade 3-star
Audit Integrity Accounting,
Governance & Risk Score Thomas White International (i) 19 7/13/08 Downgrade Most Unfavorable
Very
Conservative 1 2 3 4 Aggressive Market Edge (i) 10 7/28/04 Upgrade Buy
Chemtura Corporation is currently rated as Standard Recommendation Key: Buy Outperform Neutral Underperform Sell
having Aggressive Accounting &
Governance Risk (AGR®), receiving an AGR
score that places them in the 15th
percentile among the approximately 8,000
companies in North America rated by Audit
Integrity, indicating higher accounting and
governance risk than 85% of the other
companies.

1. Each firm has its own recommendation categories, making it difficult to compare one firm’s recommendation to another’s. Investars, a third-party research company, collects and
standardizes these recommendations using this five-point scale.
2. (i) after the Firm Name indicates an independent firm that derives no financial benefit from the nature of their recommendations.
3. (r) after Action means that a reiteration of the firm’s recommendation occurred within last twelve months.
Report created on January 11, 2010 Page 1
The content on this page is provided by third parties and not Fidelity. Fidelity did not prepare and does not endorse such content. All are third-party companies that are not affiliated with Fidelity. See each
section in this report for third-party content attribution and see page 3 for full disclosures.
 Company Research Highlights ®This Other OTC CEMJQ
is not an investment recommendation from Fidelity Investments. Fidelity provides
this information as a service to investors from independent, third-party sources.

Price on 1/8/2010: $1.22 CHEMTURA CORP

Market Capitalization: $296.4

Significant News: Last 90 Days Data provided by Thomson Reuters Street Events, Investars, Capital IQ, and Reuters Datascope.

8 5 3 1

O $1.20
O
$1.00
O O O

$0.80
O
O

$0.60
6
7 4 2 $0.40
Average Daily Volume (Millions) 10
Date of this Report:
O
January 11, 2010 5
0
October November December January
2010

January 8, 2010 Closing Price: $1.22 7 Company Events And Corporate Actions Chemtura Corporation reported unaudited

consolidated earnings results for the third quarter of 2009. For the quarter, the company
1 Analyst Actions On January 8, 2010 Price Target Research upgraded CHEMTURA
reported net sales of $681 million, earnings from continuing operations before income taxes
CORP from POSITIVE to STRONG POSITIVE. of $3 million, earnings from continuing operations of $12 million, net earnings attributable to
the company of $8 million or $0.03 per share against net sales of $924 million, earnings
December 15, 2009 Closing Price: $0.96
from continuing operations before income taxes of $28 million, earnings from continuing
2 Company Events And Corporate Actions Chemtura Corporation announced that operations of $11 million, net earnings attributable to the company of $11 million or $0.05
Chet H. Cross has been appointed as executive vice president and group president, per share for the same period last year. Net cash provided by operating activities in the
Engineered Products, effective Jan. 5, 2010. Mr. Cross comes to Chemtura from Ashland quarter ended September 30, 2009 was $81 million as compared with net cash provided by
Corporation, where he was vice president of operations for Ashland Hercules Water operating activities of $68 million in the quarter ended September 30, 2008. Capital
Technologies, primarily responsible for strategic oversight of the global manufacturing expenditures for the quarter ended September 30, 2009 were $7 million compared with
footprint and for the global operations and planning organizations. Previously, he held $35 million in the same period of 2008. For the quarter, the company reported net sales of
positions of increasing responsibility over two decades with Hercules Incorporated, most $1,885 million, loss from continuing operations before income taxes of $202 million, loss
recently as general manager for Hercules's $700 million pulp and paper business and as from continuing operations of $199 million, net loss attributable to the company of $204
president of Hercules Canada. million or $0.84 per share against net sales of $2,856 million, loss from continuing
operations before income taxes of $245 million, loss from continuing operations of $282
November 27, 2009 Closing Price: $0.74 million, net loss attributable to the company of $283 million or $1.17 per share for the same
3 Analyst Actions On November 27, 2009 Ned Davis Research dropped coverage for period last year. Net cash provided by operating activities was $26 million against $94
CHEMTURA CORP. million for the same period last year. Capital expenditures were $23 million against $94
million for the same period last year. The company currently anticipates capital spending of
November 20, 2009 Closing Price: $0.77 up to $60 million in 2009.
4 Analyst Actions On November 20, 2009 Price Target Research downgraded October 26, 2009 Closing Price: $1.13
CHEMTURA CORP from STRONG POSITIVE to POSITIVE.
8 Company Events And Corporate Actions Chemtura Corporation expected to Report

November 3, 2009 Closing Price: $0.96 Q3 2009 Results on November 4, 2009. This event was calculated by Capital IQ (Created on
October 26, 2009).
5 Company Events And Corporate Actions Chemtura Corporation expected to Report

Fiscal Year 2009 Results on February 22, 2010. This event was calculated by Capital IQ
(Created on November 3, 2009).

October 30, 2009 Closing Price: $0.96

6 Company Events And Corporate Actions Chemtura Corporation announced that
John K. Wulff and Burton M. 'Burt' Joyce have been appointed as independent members of
the company's board of directors, effective immediately. Mr. Wulff will serve on the board's
audit committee and Mr. Joyce will serve on the board's finance & pension committee. Mr.
Wulff currently serves as a director of Celanese Corporation; Sunoco Inc. and Moody's
Corporation. Mr. Joyce currently serves as a director of Norfolk Southern Corporation.
Following the appointment of Messrs. Wulff and Joyce as members of the Chemtura Board,
Stephen C. Forsyth, the company's executive vice president and chief financial officer and
Billie S. Flaherty, the company's senior vice president, general counsel and secretary,
resigned from the board.

Report created on January 11, 2010 Page 2

The content on this page is provided by third parties and not Fidelity. Fidelity did not prepare and does not endorse such content. All are third-party companies that are not affiliated with Fidelity. See each
section in this report for third-party content attribution and see page 3 for full disclosures.
 Company Research Highlights ®This Other OTC CEMJQ
is not an investment recommendation from Fidelity Investments. Fidelity provides
this information as a service to investors from independent, third-party sources.

Price on 1/8/2010: $1.22 CHEMTURA CORP

Market Capitalization: $296.4

Technical Data* Analysts' Earnings Estimates Data provided by First Call, Reuters DataScope, and StarMine

Shares Short N/A EPS Price

Days to Cover N/A
Short Interest % Change N/A $0.30 $10
Volume
Average 10-Day 1,115,399.2
$0.20 $8
Average 90-Day 2,369,713.7
% Price Above/Below
20-Day Average 14.8 $0.10 $6
50-Day Average 32.5
200-Day Average 116.4
*Data provided by Market Edge and Standard & $0.00 $4
Poors. Short Interest data provided by NASDAQ,
NYSE, or AMEX and is updated periodically and on
a monthly basis (depending on the listing
exchange), and is used to calculate Days to Cover $-0.10 $2
and Short Interest % Change.

Important Information Regarding $-0.20 $0

Third-Party Content Q1 Q2 Q3 Q4 Q1 Q2 Q3
2008 2009
The content compiled in this report is provided
by third parties and not Fidelity. Fidelity did not
prepare and does not endorse such content. Earnings Chart Legend Earnings Estimates Summary
Historical prices provided by Reuters SmartEstimate First Call Consensus $0.24
DataScope. Fundamental data provided by Analysts' consensus, weighted by accuracy of estimates SmartEstimate $0.24
Standard & Poor’s Compustat®. Earnings
Consensus Estimate Estimate High/Low $0.24/$0.24
estimates provided by Thomson Financial.
Average of all Analysts' estimates Expected Report Date February 24, 2010
Analyst recommendations performance
measurement provided by StarMine. Analyst Actual Reported EPS
recommendations data and analysis provided by
Investars. All are third-party companies that are This chart maps the range of earnings estimates of the 1 analyst following CEMJQ. The Consensus tracks the average of all analysts'
not affiliated with Fidelity. See each section in estimates. The SmartEstimate is a consensus of the analysts' estimates, weighted by ranking the timeliness and historical accuracy of the
report for complete content attribution. analysts.
This report provides quotes and data concerning
the financial markets, securities and other Audit Integrity AGR ® Equity Risk Factor* *AGR® Equity Risk Factor is a metric developed by Audit Integrity to
subjects. Content is supplied by companies that Lowest Highest correlate a firm’s AGR Score with the general expected return of a
1 2 3 4 5
are not affiliated with Fidelity ("Third-Party Expected Return Expected Return firm's stock price.
Content"). Most Third-Party Content and its
source are clearly and prominently identified.
Fidelity does not prepare, edit, or endorse Industry Comparisons Data provided by S&P Compustat
Third-Party Content. News and research are
subject to change without notice and Fidelity Price Performance (% Change) CEMJQ Industry CEMJQ Percentile Rank in Industry
does not guarantee their accuracy, timeliness, 4 Week 47.0 5.4 97
completeness or usefulness, and is not 13 Week 3.4 8.2 47
responsible or liable for any content, 52 Week -6.9 36.2 20
advertising, products, or other materials on or Total Return -34.7 19.0 7
available from third parties nor is Fidelity liable Dividend Yield N/A 2.1 N/A
for losses resulting from their use. You use
0: Worst Best: 100
Third-Party Content only at your own risk. With
respect to research reports, in order to comply Valuation Ratios (trailing 12 months) CEMJQ Industry CEMJQ Percentile Rank in Industry
with applicable laws and regulations, Fidelity Price/Earnings -0.3 27.8 57
may at times suppress the delivery of certain PE/Growth N/A 6.9 N/A
reports which are the subject of public offerings Price/Sales 0.1 2.5 4
made available to Fidelity’s brokerage Price/Book 0.8 4.0 20
customers, or otherwise. Price/Cash Flow -0.4 15.6 30
Content is provided for informational and/or 0: Worst Best: 100
educational purposes and is not intended to Company Quality Ratios CEMJQ Industry CEMJQ Percentile Rank in Industry
provide tax, legal or investment advice and Gross Profit Margin 20.6 34.9 31
should not be construed as an offer to sell, a Operating Margin (trailing 12 months) 0.6 12.4 33
solicitation of an offer to buy, or a
Net Margin -34.6 N/A N/A
recommendation for any security by Fidelity or
any Third-Party Provider. Requests for reports
Inventory Turnover (most recent fiscal year) 3.7 5.2 30
are unsolicited. Individuals are responsible for Return on Assets (trailing 12 months) -28.9 4.8 17
determining whether any investment, security or Return on Equity -247.2 11.4 4
strategy is appropriate or suitable and that 0: Worst Best: 100
neither Fidelity nor any Third-Party Provider has Growth Rates (%) CEMJQ Industry CEMJQ Percentile Rank in Industry
made any determination that any Revenue Growth (trailing 12 months vs. prior trailing 12 months) -31.3 -19.9 21
recommendation, investment, or strategy in any EPS Growth (trailing 12 months vs. prior trailing 12 months) 208.4 -82.3 95
content is suitable or appropriate based on 0: Worst Best: 100
investment objectives and financial situations.
Report created on January 11, 2010 Page 3
The content on this page is provided by third parties and not Fidelity. Fidelity did not prepare and does not endorse such content. All are third-party companies that are not affiliated with Fidelity. See each
section in this report for third-party content attribution.